News
The maker of weight loss drugs Ozempic and Wegovy broke rules around the advertising and marketing of its medication to ...
22h
Futurism on MSNThis Sleazy GLP-1 Prescription Site Is Using Deepfaked "Before-and-After" Photos of Fake Patients, and Running Ads Showing AI-Generated Ozempic BoxesMEDVi, an online hub for GLP-1 drugs, wants you to know that it's "serious" about helping you lose weight. According to its ...
Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...
Despite Lars Fruergaard Jørgensen's resignation as Novo Nordisk's CEO, its stock price has risen 10% over the past two weeks.
Whichever way the tariff winds blow (and I've no special knowledge of that), Novo Nordisk stock remains arguably the cheapest ...
3d
Zacks Investment Research on MSNNovo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside?Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the ...
Novo Nordisk has reached the end of its two-year suspension from the Association of the British Pharmaceutical Industry (ABPI) for breaches of its code of practice, after showing "significant and ...
as well as tech giant Google and pharma group AstraZeneca. Novo Nordisk’s Digital Innovation Hub will play a key role in “enhancing innovation and collaboration to create and apply artificial ...
1d
News-Medical.Net on MSNISSCR and Harvard launch free online course on stem cell medicineThe International Society for Stem Cell Research (ISSCR) announces the launch of a new online continuing education course, ...
Keynotes from Bayer, Lonza, MSD, Novo Nordisk, Recipharm, and Teva will showcase how connected platforms and AI can streamline the development of new medicines BARCELONA, May 27, 2025 /PRNewswire/ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results